Pure Global AI
Manufacturer profile

PRIMA SURGICAL COMPANY

TaiwanTaiwan, Province of China2 products registeredNov 02, 2017 – Jan 26, 2018
VerifiedTFDA · Taiwan Food and Drug Administration registry
2
Total products
2
Product types
2
Active products
Jan 2018
Latest registration
Company details
Address
新北市樹林區中正路415號2樓之2
Regulatory footprint
Search PRIMA SURGICAL COMPANY across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Recent registrations
Latest 5 products registered by this manufacturer
"Tien Shan" endoscope attachment (unsterilized)
Class 1
Jan 26, 2018
"PRIMA" Manual surgical instrument for general use (Non-Sterile)
Class 1
Nov 02, 2017
Most popular products
Products with most registrations
"Tien Shan" endoscope attachment (unsterilized)
1 registrations
"PRIMA" Manual surgical instrument for general use (Non-Sterile)
1 registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
PRIMA SURGICAL COMPANY
2 products
Recent registered products
Most recent products (showing top 20)
"Tien Shan" endoscope attachment (unsterilized)
Registered: Jan 26, 2018 • Expires: Jan 26, 2023
Risk Class
Class 1
AR
PRIMA SURGICAL COMPANY
"PRIMA" Manual surgical instrument for general use (Non-Sterile)
Registered: Nov 02, 2017 • Expires: Nov 02, 2027
Risk Class
Class 1
Type
MD
AR
PRIMA SURGICAL COMPANY
About this profile

Explore comprehensive manufacturer profile for PRIMA SURGICAL COMPANY based in Taiwan, Province of China through Pure Global AI's free Taiwan medical device database. This manufacturer has 2 products registered in Taiwan across 2 unique product categories. Their regulatory history spans from Nov 02, 2017 to Jan 26, 2018.

This page provides detailed insights including 2 recent product registrations, 2 most popular products with "Tien Shan" endoscope attachment (unsterilized) having 1 registrations, and 1 authorized representatives including PRIMA SURGICAL COMPANY. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.